LUHS
LUHS
Lower Urinary H Symptom
"lower urinary tract symptoms" LUTS management
| Symptom | Definition |
|---|---|
| Frequency | Patient voids too often during the day (>5-6 times/day) |
| Nocturia | Wakes at night at least once to void (>2x/night warrants investigation) |
| Urgency | Sudden compelling desire to void that is difficult to defer |
| Urge incontinence | Involuntary leakage immediately preceded by urgency |
| Stress incontinence | Leakage with increased intra-abdominal pressure (cough, sneeze, exercise) |
| Strangury | Constant sensation of needing to void |
| Symptom | Description |
|---|---|
| Hesitancy | Difficulty initiating micturition |
| Poor/weak stream | Reduced flow rate, not improved by straining |
| Intermittency | Flow stops and starts |
| Straining | Requires Valsalva maneuver to aid voiding |
| Terminal dribbling | Stream ends slowly |
| Symptom | Description |
|---|---|
| Incomplete emptying | Sensation of persistent bladder fullness after voiding |
| Post-micturition dribble | Involuntary urine loss immediately after finishing voiding (due to retained urine in the urethra - NOT caused by BOO and NOT improved by prostatectomy) |
| Cause | Predominant LUTS Type |
|---|---|
| BPH / bladder outlet obstruction | Voiding (+ secondary storage) |
| Overactive bladder (OAB) | Storage |
| Urinary tract infection (UTI) | Storage (irritative) |
| Urethral stricture | Voiding |
| Neurogenic bladder (DM, stroke, Parkinson's, MS) | Mixed |
| Bladder cancer / CIS | Storage (irritative) |
| Prostatitis | Irritative/voiding |
| Bladder stones | Storage (irritative) |
Note: A man with BOO from BPH may also develop secondary storage LUTS due to chronic detrusor irritability - Campbell-Walsh-Wein Urology
| Severity | Approach |
|---|---|
| Mild (IPSS 0-7) | Watchful waiting + lifestyle modification |
| Moderate-Severe storage LUTS (OAB) | Antimuscarinics (oxybutynin, solifenacin), beta-3 agonists (mirabegron) |
| Moderate-Severe voiding LUTS (BPH/BOO) | Alpha-1 blockers (tamsulosin, alfuzosin), 5-alpha reductase inhibitors (finasteride, dutasteride) |
| Combination (storage + voiding) | Alpha blocker + antimuscarinic or + mirabegron |
| Refractory / severe BOO | TURP, laser prostatectomy, other surgical options |
2026 AUA Guideline Update: The AUA 2026 guideline on medical management of LUTS/BPH was published in August 2026, representing the most current evidence-based recommendations for pharmacotherapy. A 2025 systematic review on self-management interventions for men with LUTS confirms behavioral strategies (fluid management, timed voiding, bladder training) have meaningful efficacy, particularly for storage symptoms.